Search
Search Constraints
You searched for: ISSN 0301-0082Limit your search
- 612.8 717
- Neurobiologie -- Périodiques 717
- Neurobiology -- Periodicals 717
- Neurology -- Periodicals 717
- 3α-HSD 3α-hydroxy-steroid dehydrogenase -- 3α-HSORs 3α-hydroxysteroid oxirreductases -- 3β-HSD 3β-hydroxy-steroid dehydrogenase -- 5α-DHP 5-α-pregnane-3, 20-dione (5α-dihydroprogesterone) -- 5α-DHT 5α-dihydrotestosterone -- 7α-OH-DHEA 7α-hydroxydehydroepiandrosterone -- 7β-OH-DHEA 7β-hydroxydehydroepiandrosterone -- AC adenylate cyclase -- ACTH adrenocorticotropic hormone -- AF activation function domain -- AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid -- AP-1 activation protein 1 -- AQP4 aquaporin-4 -- AR androgen receptor -- BBB blood brain barrier -- BDNF brain derived neurotrophic factor -- CDK cyclic-dependent-kinases -- CNS central nervous system -- COX cyclooxygenase -- CREB cAMP-responsive element binding -- CSF cerebrospinal fluid -- CYP11A1 cytochrome P450 side chain cleavage -- CYP17 cytochrome P450 side-chain cleavage at carbon 17 -- DBD DNA binding domain -- DHEA dehydroepiandrosterone -- DHEAS dehydroepiandrosterone sulfate -- DHT dihydrotestosterone -- ER estrogen receptors -- GABA γ-aminobutiric acid -- GAP growth-associated protein -- GFAP glial fibrillary acidic protein -- Gi inhibitory G protein -- GOS Glasgow outcome scale -- GOS-E Glasgow outcome scale-extended -- GPx glutathione peroxidase -- Gs stimulatory G protein -- GSC Glasgow Coma Scale -- GSH reduced glutathione -- HDL high-density lipoprotein -- HSP heat shock protein -- HST hydroxysteroid sulfotransferase -- IF inhibition function domain -- IL interleukin -- iNOS inducible nitric oxide synthase -- LBD ligand binding domain -- LDL low-density lipoprotein -- LPS lipopolysaccharide -- MAPK mitogen-activated protein kinases -- MBP myelin basic protein -- MCAO middle cerebral artery occlusion -- MDA malondialdehyde -- MPA medroxyprogesterone acetate -- mPTP mitochondrial permeability transition pore -- mPR membrane progesterone receptor -- NGF nerve growth factor -- NMDA N-methyl-d-aspartate -- NO nitric oxide -- NOS nitric oxide synthase -- PGE2 prostaglandin E2 -- PGMCR progesterone membrane receptor component -- PI3K phosphatidylinositol 3-kinase -- PKA protein kinase A -- PKC protein kinase C -- PKG protein kinase G -- PR progesterone receptor -- PRE progesterone response element -- SCI spinal cord injury -- Shh sonic-hedgehog -- SOD superoxide dismutase -- SR-B1 scavenger receptor B1 -- StAR steroidogenic acute regulatory protein -- TBI traumatic brain injury -- TGF transforming growth factor -- TNF-α tumor necrosis factor α -- VEGF vascular endothelial growth factor 3
- Neuroactive steroids -- Neurosteroids -- Apoptosis -- Brain injury -- Neurodegeneration -- Spinal cord injury 3
- 17 beta-estradiol (PubChem CID: 5757) -- Testosterone (PubChem CID: 6013) -- Progesterone (PubChem CID: 5994) -- LPS (PubChem CID: 11970143) -- Tibolone (PubChem CID: 444008) -- Dehydroepiandrosterone (PubChem CID: 5881) -- Dihydrotestosterone (PubChem CID: 10635) 2
- AAV adeno-associated viral vectors -- ALS amyotrophic lateral sclerosis -- ApoE apolipoprotein E -- AQP4 aquaporin-4 -- AD Alzheimer's disease -- ASD autism spectrum disorders -- BBB blood brain barrier -- BD bipolar disorder -- Ca2+ calcium -- CALHM1 calcium homeostasis modulator 1 -- CUS chronic unpredictable stress -- Cx connexin -- DAAO d-amino acid oxidase -- DBS deep brain stimulation -- Disc1 disrupted-in-schizophrenia -- EAAT2 excitatory amino acid transporter -- ECS electroconvulsive stimulation -- EC-SOD extracellular SOD -- FXS Fragile X syndrome -- GFAP glial fibrillary acidic protein -- GJ gap junction channel -- GLT glutamate transporter -- GPCs glial progenitor cells -- GPx glutathione peroxidase -- GR glucocorticoid receptors -- GST glutathione-S-transferase -- HD Huntington's disease -- HO-1 heme oxygenase 1 -- IP3R2 inositol triphosphate receptor 2 -- K+ potassium -- Kir4.1 inward rectifier K+ channel 4.1 -- L-AAA l-α-aminoadipate -- LDH lactate dehydrogenase enzyme -- MCT monocarboxylate transporters -- LTD long-term depression -- LTP long-term potentiation -- MD major depression -- MeCP2 methyl-CpG-binding protein-2 -- MSNs medium spiny neurons -- mPFC medial prefrontal cortex -- NAAMFs neuronal activity associated magnetic fields -- NCX sodium/calcium exchangers -- NFAT nuclear factor of activated T-cells -- NG2 nerve-glia antigen 2 -- NO nitric oxide -- NOR novel object recognition -- NT-3 neurotrophin-3 -- O2− superoxide -- OHC hydroxycholesterol -- ONOO− peroxynitrite -- PD Parkinson's disease -- PLC phospholipase C -- RTT Rett syndrome -- ROS reactive oxygen species -- SOC store operated channels -- SOD superoxide dismutase -- SWA slow wave sleep activity -- TeNT tetanus neurotoxin -- TNFα tumor necrosis factor α -- TMS trans-magnetic stimulation -- TRPC transient potential channels -- UPS ubiquitin-proteasome degradation system -- VGCC voltage-gated calcium channels 2
- AB amyloid beta -- AD Alzheimer's disease -- AGE advanced glycation end products -- AKT protein kinase B -- BAD Bcl 2 antagonist of death -- BBB blood brain barrier -- Bcl-2 B-cell lymphoma 2 -- Bcl-XL B-cell lymphoma extra large -- Bim Bcl-2 interacting mediator of death -- cAMP cyclic adenosine monophosphate -- CREB cAMP response element-binding protein -- CNS central nervous system -- CSF cerebrospinal fluid -- DA dopamine -- DLB dementia with lewy bodies -- DPP-4 dipeptidyl peptidase 4 -- ERK extracellular signal regulated kinase -- FoxO1 forkhead box O1 -- GLP-1 glucagon like peptide-1 -- GLP-1R glucagon like peptide-1 receptor -- GSK-3b glycogen synthase kinase 3b -- 6-OHDA 6-hydroxydopamine -- IDE insulin degrading enzyme -- IGF-1 insulin like growth factor-1 -- IGF-1R insulin like growth factor-1 receptor -- IRS insulin receptor substrate -- LTP long term potentiation -- MAP-K mitogen associated protein kinase -- MCI mild cognitive impairment -- mTOR mammalian target of rapamycin -- MPTP 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine -- NF-kB nuclear factor kappa-light- chain-enhancer of activated B cells -- NIRKO brain/neuron-specific insulin receptor knockout -- PD Parkinson's disease -- PDD Parkinson's disease dementia -- PI3-K phosphoinositide 3-kinase -- PGC1α peroxisome-proliferator activated receptor gamma coactivator-1alpha -- PKA protein kinase A -- ROS reactive oxygen species -- SNpc substantia nigra pars compacta -- TH tyrosine hydroxylase -- T2DM type 2 diabetes -- UPDRS Unified Parkinson's Disease rating Scale 2
- ACBP acyl-CoA binding protein -- ACC acetyl-CoA carboxylase -- AgRP agouti-related protein -- ALKO astrocytic leptin-receptor knockout -- AMPK AMP-activated kinase -- ApoE apolipoprotein E -- AR androgen receptor -- BBB blood brain barrier -- CART cocaine-and-amphetamine-regulated transcript -- CB1 cannabinoid receptor 1 -- DMH dorsal-medial hypothalamus -- DBI diazepam-binding inhibitor -- DAG diacylglycerol -- DIO diet-induced obesity -- DR diet-resistant -- ER estrogen receptor -- GABA gamma-amino-butyric acid -- FA fatty acid -- GFAP glial fibrillary acidic protein -- GHSR1a growth hormone secretagogue receptor 1a -- GLUT glucose transporter -- GnRH gonadotropin-releasing hormone -- HFD high fat diet -- IGF insulin-like growth factor -- IL interleukin -- IPSC inhibitory post-synaptic currents -- JNK c-Jun N-terminal kinase -- KO knock-out -- LCFA long-chain fatty acids -- LH lateral hypothalamus -- MC4R melanocortin 4 receptor -- mIPSCs mini inhibitory post synaptic currents -- MSH melanocyte stimulating hormone -- NCAM neural-cell adhesion molecule -- NfKB nuclear factor KB -- NMDA N-methyl-d-aspartate -- NO nitric oxide -- NPY neuropeptide Y -- OBR leptin receptor -- ODN octadecaneuropeptide -- PeN periventricular nucleus -- POMC proopiomelanocortin -- PPARγ peroxisome proliferator-activated receptor gamma -- PSA polysialic acid -- PVN paraventricular nucleus -- SCN subrachiasmatic nucleus -- sEPSCs spontaneous excitatory post-synaptic currents -- SNAP25 synaptosomal-associated protein 25 -- SON supraoptic nucleus -- STAT signal transducer and activator of transcription -- T2D type 2 diabetes -- TAG triacylglycerol -- TNF tumor necrotizing factor -- VMH ventromedial hypothalamic nucleus -- WT wild-type 2